Physician profile
Christopher Goettl
NPI 1609219633
$220,103.77
in general payments reported to CMS, 2019-2025
28 companies · $32K in 2025
The $32K reported for 2025 was more than what 95% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,408 · 2020: $22K · 2021: $35K · 2022: $22K · 2023: $29K · 2024: $76K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $101K · Consulting Fee: $21K · Food and Beverage: $12K · Travel and Lodging: $3,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100,687.50 |
| Consulting Fee | $20,795.83 |
| Food and Beverage | $11,865.01 |
| Travel and Lodging | $3,924.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $181,249.94 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Bard Peripheral Vascular, INC. | $21,187.29 | 2019-2025 | Venovo, Trek |
| Siemens Medical Solutions USA, INC. | $6,318.18 | 2024-2025 | Artis Q Ceiling, Artis Q Floor |
| Penumbra, INC. | $3,393.95 | 2019-2025 | Indigo System, Penumbra System, Red 72 |
| Boston Scientific Corporation | $1,983.24 | 2019-2025 | Embold Fibered, General - Embolics, Therasphere Y90 Glass Microspheres 10 Gbq |
| Inari Medical, INC. | $1,119.01 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $906.91 | 2023-2025 | Azurion 5 M20 |
| Histosonics, INC. | $869.32 | 2024-2025 | |
| Terumo Medical Corporation | $694.61 | 2019-2023 | Progreat, Angio-Seal |
| Medtronic, INC. | $421.85 | 2021-2025 | Concertotm, Inceptiv, Abre |
| Imperative Care, INC | $338.24 | 2021-2025 | Zoom 88-T Large Distal Platform, Symphony Catheter |
| Asahi Intecc USA, INC. | $310.73 | 2025 | Asahi Interventional Radiology Wires, Asahi Peripheral Vascular Wires |
| Ekos Corporation | $278.92 | 2019 | |
| Telix Pharmaceuticals | $217.38 | 2023 | Illuccix |
| Depuy Synthes Sales INC. | $132.38 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $124.90 | 2023-2025 | Trinav Infusion System |
| Becton, Dickinson and Company | $110.41 | 2024-2025 | Lutonix Drug Coated Balloon |
| Angiodynamics, INC. | $98.17 | 2020 | |
| Abbott Laboratories | $79.40 | 2024 | Absolute Pro |
| Medtronic USA, INC. | $58.22 | 2019-2020 | |
| Stryker Corporation | $38.43 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Avanos Medical | $34.10 | 2023 | Generator |
| Relievant Medsystems, INC. | $29.17 | 2021 | |
| Ethicon US, LLC | $28.91 | 2020-2021 | |
| Allergan, INC. | $28.72 | 2022 | |
| Okami Medical, INC. | $19.03 | 2024 | Lobo |
| Astellas Pharma US INC | $18.81 | 2019 | |
| Cook Medical LLC | $13.55 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Goettl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.